Abrysvo Vaccine Rawang

Abrysvo Vaccine in Rawang, Selangor

At Klinik Elysiana, we prioritize the health and safety of our community. The Abrysvo vaccine (manufactured by Pfizer) is the first bivalent RSV vaccine approved by the FDA. It is designed to provide robust protection against respiratory illnesses caused by RSV.

Administered as a single-dose injection, it is highly effective and has passed rigorous clinical trials, ensuring it meets the highest safety standards for our patients in Rawang and surrounding areas.

Protection for Pregnant Mothers

Maternal vaccination is one of the most effective ways to protect newborns. Administering the Abrysvo vaccine to pregnant women between 32 to 36 weeks of pregnancy allows the mother's body to produce strong antibodies.

These antibodies are safely passed to the baby through the placenta, providing the infant with critical passive immunity from their very first day of life up until they are 6 months old—the most vulnerable period for severe RSV infections.

Safeguarding Seniors (60+ Years)

As we age, our immune systems naturally weaken, making it harder to fight off infections. Seniors, particularly those aged 60 and above or those managing chronic health conditions like diabetes, asthma, or heart disease, are at a significantly higher risk.

For older adults, an RSV infection can quickly escalate into severe pneumonia or exacerbate existing underlying conditions. Getting the Abrysvo vaccine drastically reduces the risk of hospitalization and ensures peace of mind for both you and your family.